Ariel Roguin

285 posts

Ariel Roguin

Ariel Roguin

@ArielRoguin

Head of Cardiology, Hillel Yaffe Medical Center. Professor of Cardiology, Tecnion Israel Institue of Technology.

Israel Katılım Mayıs 2023
80 Takip Edilen57 Takipçiler
Ariel Roguin retweetledi
Mamas A. Mamas
Mamas A. Mamas@mmamas1973·
This is a really interesting paper- 1 in 300 citations are now fabricated with a 12- fold increase in past 2-3 years, probably reflecting use of AI. Via @ArielRoguin ( his sons paper) Fabricated citations: an audit across 2·5 million biomedical papers - The Lancet thelancet.com/journals/lance…
English
8
36
98
27.6K
Ariel Roguin retweetledi
Johns Hopkins Cardiology
Johns Hopkins Cardiology@hopkinsheart·
Please join us in welcoming our new Interventional Cardiology Fellows @DanMatasicMD and @DrRishiC for the 2026-2027 academic year! We are thrilled to have them join the program and look forward to all they will accomplish in the year ahead!
Johns Hopkins Cardiology tweet media
English
1
4
43
3.1K
Ariel Roguin retweetledi
Heart Rhythm Society
Heart Rhythm Society@HRSonline·
How's this for a #ThrowbackThursday? ⏪ #HRS2026 attendees — swing by the EP & HRS History display in the Grand Concourse, North Building Level 3 and travel through the evolution of electrophysiology and HRS. You won't want to miss it. #tbt #EPeeps
Heart Rhythm Society tweet mediaHeart Rhythm Society tweet mediaHeart Rhythm Society tweet mediaHeart Rhythm Society tweet media
English
1
3
11
1.1K
Ariel Roguin retweetledi
Hany Ragy
Hany Ragy@Hragy·
Don’t use MCS in non shock stable high risk PCI is the right conclusion. There is no scientific basis for advising selective use for a device that showed no benefit and potential harm in a subset of patients
Markz Sinurat@markzroland

CHIP-BCIS3 🚨 Routine LV unloading (Impella) in complex PCI NO benefit on MACE, but ↑ mortality signal (CV HR ~1.9). 👉 Protection ≠ outcome. Use MCS selectively—not routinely in stable high-risk PCI. #ACCAsia @ACCinTouch @JACCJournals

English
1
1
11
1.9K
Ariel Roguin retweetledi
Khurram Nasir
Khurram Nasir@khurramn1·
Great work @pnatarajanmd @aklfahed 👏👏 Also grateful to our @AJPCardio editorial team/reviewer as well as authors for getting these insights for everyone within a rapid time line (about 3 weeks from submission->review->revisions->acceptance->publication) We value the amazing work led for months and years by the authors, and this is our commitment in fast tracking top science We look forward to reviewing and partnering with you on your best work!!
Pradeep Natarajan@pnatarajanmd

Guidelines recommend risk stratification for secondary prevention to support more aggressive LDL-C-lowering. Our study by @JHalfordMD and with @aklfahed shows how coronary artery disease polygenic risk scoring can further improve risk stratification in secondary prevention sciencedirect.com/science/articl… @ASPCardio @AJPCardio

English
0
8
33
4.5K
Ariel Roguin retweetledi
Davide Capodanno
Davide Capodanno@DFCapodanno·
Here we go again: the MITRA-FR vs COAPT nightmare, revisited. Two LAAO trials, two different results—unsurprising, for many reasons. In CHAMPION-AF, among patients with atrial fibrillation, left atrial appendage closure was noninferior to NOACs for cardiovascular death, stroke, or systemic embolism, and superior for non–procedure-related bleeding. #ACC26 nejm.org/doi/full/10.10…
Davide Capodanno tweet media
English
11
47
130
25.4K
Ariel Roguin retweetledi
Evandro Martins F. MD
Evandro Martins F. MD@evandrofilhobr·
🫀 Limus vs. Paclitaxel DCB for In-Stent Restenosis, meta-analysis of 6 RCTs (1,038 pts) in AJC 2026: ➡️ PCB reduced TLR vs LCB (RR 1.48; p=0.04) ➡️ Mortality, MI, MACE, stent thrombosis: no difference ➡️ Angiographic outcomes: equivalent Modest advantage of paclitaxel in preventing restenosis, without impacting hard clinical endpoints. 🔗 doi.org/10.1016/j.amjc…
Evandro Martins F. MD tweet media
English
0
11
40
2.3K
Ariel Roguin retweetledi
Kyla Lara-Breitinger, MD
Kyla Lara-Breitinger, MD@kylalaraMD·
Still processing that our Dr. @LermanAmir has passed. Just last wk, we celebrated our “Happy Healthy Heart” book under his leadership- his passion project over yrs. A GIANT in cardiology, he cared about young faculty, & I was privileged to be one of his mentees. @DrLopezJimenez
Kyla Lara-Breitinger, MD tweet mediaKyla Lara-Breitinger, MD tweet mediaKyla Lara-Breitinger, MD tweet mediaKyla Lara-Breitinger, MD tweet media
English
1
3
33
1.7K
Ariel Roguin retweetledi
Keele University 🐿️
Keele University 🐿️@KeeleUniversity·
Professor Mamas Mamas (@mmamas1973) saves lives. Not only does he treat some of the region’s sickest patients who have coronary heart disease, his research is changing the way in which cardiology procedures are being performed around the world 💚 ➡️ keele.ac.uk/nhs
English
2
18
65
9.6K
Ariel Roguin retweetledi
Shahar Lavi
Shahar Lavi@ShaharLavi1·
@SVRaoMD Very sad to hear about the passing of Amir Lerman, my mentor at Mayo Clinic and a true leader in the cardiology field. His dedication to advancing cardiovascular medicine inspired countless colleagues and trainees. May his memory be a blessing.
English
0
2
5
792
Ariel Roguin retweetledi
Swati Gupta
Swati Gupta@hrswatigupta·
Google loves keeping valuable websites hidden from you. Here are 13 incredibly useful websites you probably didn’t know existed. Trust me, you’ll want to bookmark these 🔖
Swati Gupta tweet media
English
54
92
350
67.3K

Keşfet

@TheLancet @DanMatasicMD @DrRishiC @pnatarajanmd @aklfahed @AJPCardio @EJHFEiC @JanBiegus